drug · antibody

tobevibart

Phase 3updated 3mo ago

by $VIR Vir Biotechnology, Inc.🔗 ChEMBL

Phase 3

community read0 votes

Antibody drug with a maximum clinical stage of Phase 2 (across all indications), with 3 investigational indications.

all catalysts(0)

nothing on the calendar yet

Trials studying tobevibart

phase3A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infectionactive not recruitingn=124
phase3A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtiderecruitingn=150
phase2A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infectionactive not recruitingn=100

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 18m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · antibody

save

tobevibart

Phase 3updated 3mo ago

by $VIR Vir Biotechnology, Inc.🔗 ChEMBL

Phase 3

community read0 votes

Antibody drug with a maximum clinical stage of Phase 2 (across all indications), with 3 investigational indications.

all catalysts(0)

nothing on the calendar yet

Trials studying tobevibart

phase3A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infectionactive not recruitingn=124
phase3A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtiderecruitingn=150
phase2A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infectionactive not recruitingn=100

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 18m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

tobevibart

all catalysts(0)

Trials studying tobevibart

News(0)

Report a data issue

comments(0)

tobevibart

all catalysts(0)

Trials studying tobevibart

News(0)

Report a data issue

comments(0)